ROSE Diagnostics
ROSE Diagnostics' objective is to improve cancer diagnostics by moving the pathology lab to the cancer biopsy clinic
Seed ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredSep 27, 2022 (4 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | undisclosed | — | — |
Timeline
- Website created
Founders and team
EB
Eric Brouwer Founder
Companies like ROSE Diagnostics
TTvaster Genkalp$1.25M Series A · Apr 2025
DDxcover$6.2M Series A · Feb 2025
AAcurion$4.3M Seed · Apr 2026
TTileBio$2.15M Seed · Mar 2026
AAignostics$34M Series B+ · Oct 2024
RRedcliffe Lifetech$42M Series B+ · Sep 2024
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/rose-diagnostics (get a free API key).